Advertisement
The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV All Topics Relating to HIV
HIV/AIDS Conferences
Upcoming Conferences

November 19-22, 2009
Jacksonville, Fla.
22nd Annual Conference of the Association of Nurses in AIDS Care

More upcoming HIV/AIDS meetings >>

Conference Calendar
2009
NOV. DEC.
2010
JAN. FEB.
MARCH APRIL
MAY  

The Body's Conference Coverage
ICAAC 2009
HIV/AIDS TREATMENT STRATEGIES: In the MERIT Trial, Maraviroc Decreased Levels of Immune Activation Earlier Than Efavirenz

HIV/AIDS & RACE/GENDER: Virologic Suppression Is Less Likely Among Antiretroviral-Experienced Black Women. But Why?

HIV PREVENTION & TRANSMISSION: The Evolution of HIV Testing in the U.S.: Are We at the Cusp of a New Era?

HIV/AIDS TREATMENT STRATEGIES: Raltegravir Exhibits More Lipid-Friendly Profile Than Efavirenz, STARTMRK Subanalysis

DRUGS IN DEVELOPMENT: Vicriviroc Safe and Effective in Treatment-Experienced HIV-Infected Patients at 96 Weeks

More from ICAAC 2009 >>

 

CROI 2009
COMPLICATIONS & COINFECTIONS: HPV, Anal Cancer and Cervical Cancer: An Update on Pathogenesis, Treatment and Prevention

ANTIRETROVIRAL THERAPY: Ever Upward: "When to Start" Debate Turns to CD4 Count of 500

COMPLICATIONS & COINFECTIONS: HIV on Par With Smoking, Diabetes as Risk Factor for Atherosclerosis, Large Study Finds

COMPLICATIONS & COINFECTIONS: Jens Lundgren, M.D., Discusses New Findings Regarding MI Risk of Specific Antiretrovirals

ANTIRETROVIRAL THERAPY: The Next Generation of Boosters: Promising Data on Potential Alternatives to Ritonavir

More from CROI 2009 >>

 
IAS 2009
HIV/AIDS TREATMENT STRATEGIES: Inflammation and HIV: A New Paradigm

DEVELOPING WORLD: How Will Barack Obama Change the Global (and Domestic) Fight Against HIV?

HIV PREVENTION & TRANSMISSION: Revisiting Priorities in the Prevention of Mother-to-Child HIV Transmission

HIV/AIDS TREATMENT STRATEGIES: African Americans, Women Have Lower Virologic Response Rates in Both Arms of Head-to-Head Antiretroviral Trial

More from IAS 2009 >>

 

ICAAC/IDSA 2008
CLINICAL MANAGEMENT: Starting HAART: Should 500 Become the New 350?

COMPLICATIONS AND COINFECTIONS: HAART Use Improves Hepatitis B Vaccine Response, Even at High CD4 Counts

CLINICAL MANAGEMENT: Continuous HAART Associated With Decreased Bone Mineral Density, SMART Substudy Finds

HIV/HEPATITIS B COINFECTION: HAART Use Improves Hepatitis B Vaccine Response, Even at High CD4 Counts

More from ICAAC/IDSA 2008 >>

Past Conference Coverage
Advertisement